CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to APTOF

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '26
APTOFPhase 2

Tuspetinib Phase 2 Est. Readout

Tuspetinib
Nov 2026~
CT.gov
00%
Competitive Landscape

2 competitors in Leukemia, Myeloid, Acute

View Full Landscape
Drug Information

Target Indication

Leukemia, Myeloid, Acute

Clinical Trial

NCT03850574

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.